Venor Pharma Limited Fentanyl Export Data — India (DGFT 2022–2026)

Name: Venor Pharma Limited Fentanyl Export Records India — #2 Exporter, 76 Shipments, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fentanyl

India Pharmaceutical Trade Intelligence

$3.8M15 Suppliers53 CountriesHS 30049099

ExportsIndia → PHILIPPINES18.7%India → SRI LANKA12.3%

ImportsGREECE → India$8

#1 Supplier: TROIKAA PHARMACEUTICALS

Venor Pharma Limited — Fentanyl Exporter #2 | $1.2M Trade Value | TransData Nexus | TransData Nexus

Venor Pharma Limited — Fentanyl Exporter Profile

Indian Pharmaceutical Exporter · #2 for Fentanyl · $1.2M export value · DGFT Verified

Venor Pharma Limited is the #2 Indian exporter of Fentanyl with $1.2M in export value and 76 verified shipments. Venor Pharma Limited holds a 32.7% market share in Fentanyl exports across 24 countries. The company exports 9 pharmaceutical products worth $8.6M across 4 therapeutic categories.

Venor Pharma Limited — Fentanyl Export Profile: Buyers & Destinations

Venor Pharma Limited Fentanyl export treemap — buyers and destination countries | TransData Nexus

Where Does Venor Pharma Limited Export Fentanyl?

Country	Value	Shipments	Share
OMAN	$171.3K	20	18.0%
SRI LANKA	$150.0K	3	15.8%
COTE D IVOIRE	$124.8K	5	13.1%
SENEGAL	$109.8K	5	11.6%

Who Are the Top Buyers of Fentanyl from Venor Pharma Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	KENYA	$374.0K	34
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$150.0K	3
M/S. NATIONAL PHARMACEUTICAL	ZIMBABWE	$56.9K	2
M/S. PHARMACIE CENTRALE DE GUINEE	GUINEA	$50.0K	1
CHIDI DOZIE,SUPERINTENDENT	NIGERIA	$26.6K	4
M S DITA ESTFARM SRL	MOLDOVA	$25.9K	1
M/S ALRAZI PHARMACY	OMAN	$23.4K	3
M/S.AL RAZI PHARMACY	OMAN	$21.8K	1
M/S. AL RAZI PHARMACY	OMAN	$21.1K	1
M/S.CAMEG-TOGO	TOGO	$21.1K	1

Venor Pharma Limited supplies Fentanyl to 28 buyers globally. The largest buyer is TO THE ORDER OF (KENYA), followed by STATE PHARMACEUTICALS CORPORATION (SRI LANKA) and M/S. NATIONAL PHARMACEUTICAL (ZIMBABWE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fentanyl Formulations Does Venor Pharma Limited Export?

Product Description / Formulation	Value	Shipments
BRAND.VERFEN INJ. FENTANYL CITRATE USP 50MCG/ML,2ML AMP.(B.NO.EN012360,EN012361,EN012362 MD.NOV.2023 ED.OCT.2025NOS	$124.8K	3
FENTANYL CITRATE INJECTION USP 50MCG/ML,	$100.0K	2
BRAND. VERFEN-2ML INJ. FENTANYL CITRATE	$89.1K	5
PHARMACEUTICALS:BRAND. VERFEN INJ. FENTANYL CITRATE USP 50MCG/ML,2ML AMP.B.NO.EN012359. MD.NOV.2023 ED.OCT.2025NOS	$50.4K	3
FENTANYL CITRATE INJ USP 50MCG ML 2ML AMP VERFEN BN EN012258 EN012259 EN012260 MD DEC 2022 ED NOV 2024 360000 AMP	$50.0K	1
BRAND-VERFEN INJ. FENTANYL CITRATE USP 5	$50.0K	1
PHARMACEUTICALS:BRAND.VERFEN-10ML INJ.FENTANYL CITRATE USP 50MCG/ML,10ML AMP.BN.EN022451,EN022452 MD.OCT.24 ED.SEPT.26	$44.0K	1
PHARMACEUTICALS BRAND VERFEN INJ. FENTANYL CITRATE USP 50MCG/ML 2ML AMPOULE B.NO.EN012451,EN012452 MD.FEB.24 ED.JAN.26	$36.5K	3
BRAND VERFEN-10ML INJ FENTANYL CITRATE U	$27.0K	2
VERFEN INJ.FENTANYL CITRATE USP 50MCG/ML	$26.6K	6

Venor Pharma Limited exports 47 distinct Fentanyl formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BRAND.VERFEN INJ. FENTANYL CITRATE USP 50MCG/ML,2ML AMP.(B.N with 3 shipments worth $124.8K.

How Does Venor Pharma Limited Compare to Nearest Fentanyl Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	TROIKAA PHARMACEUTICALS LIMITED	$1.3M	48	14	$26.4K
2	VENOR PHARMA LIMITED ★	$1.2M	76	24	$16.2K
3	RUSAN PHARMA LIMITED	$293.4K	19	8	$15.4K
4	VERVE HUMAN CARE LABORATORIES	$216.7K	20	12	$10.8K

Venor Pharma Limited ranks #2 among 15 Indian Fentanyl exporters. Average shipment value of $16.2K compared to the market average of $248.7K. The closest competitors by value are TROIKAA PHARMACEUTICALS LIMITED and RUSAN PHARMA LIMITED.

Which Indian Ports Ship Fentanyl Exports?

Port	Shipments	% Share
DELHI AIR	65	29.3%
DELHI AIR CARGO ACC (INDEL4)	63	28.4%
Delhi Air	14	6.3%
SAHAR AIR CARGO ACC (INBOM4)	10	4.5%
SAHAR AIR	10	4.5%
AHEMDABAD AIR ACC (INAMD4)	8	3.6%
HYDERABAD ACC (INHYD4)	7	3.2%
AHEMDABAD AIR	7	3.2%

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Fentanyl Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Venor Pharma. The escalation of conflicts in the Middle East, particularly the Red Sea crisis, has led to disruptions in key shipping routes. Major carriers have suspended or restricted transits through the Strait of Hormuz and the Red Sea–Suez Canal corridor, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions are particularly concerning for time-sensitive pharmaceutical shipments, potentially affecting the timely delivery of products like Diazepam and Fentanyl.

In the United States, recent trade policies have introduced additional complexities. The imposition of a 25% reciprocal tariff on Indian imports, effective August 2025, and the subsequent increase to a 50% tariff linked to India's energy trade decisions, have raised concerns about the cost competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org) While pharmaceuticals have been largely exempt from these tariffs, the potential for future policy shifts necessitates vigilance.

The European Union's implementation of the Falsified Medicines Directive (FMD) has also impacted Indian exporters. Compliance with stringent serialization and traceability requirements has increased operational costs. For companies like Venor Pharma, ensuring adherence to these regulations is crucial to maintain market access and competitiveness in the EU.

Venor Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA, WHO, and EU authorities enforcing stringent Good Manufacturing Practice (GMP) standards. Instances such as the FDA's warning letter and import alert issued to Viatris' facility in Indore, India, in December 2024, highlight the critical importance of compliance. (en.wikipedia.org) For Venor Pharma, maintaining impeccable quality standards and regulatory compliance is essential to avoid similar setbacks and to sustain its export operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fentanyl shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venor Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 76 individual customs records matching Venor Pharma Limited exporting Fentanyl, covering 47 formulations to 24 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 53+ countries, 98+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fentanyl

Fentanyl

Venor Pharma Limited — Fentanyl Exporter Profile

Venor Pharma Limited — Fentanyl Export Profile: Buyers & Destinations

Where Does Venor Pharma Limited Export Fentanyl?

Who Are the Top Buyers of Fentanyl from Venor Pharma Limited?

What Is India's Total Fentanyl Export Value and How Much Does Venor Pharma Limited Contribute?

What Is the Average Shipment Value for Venor Pharma Limited's Fentanyl Exports?

How Does Venor Pharma Limited Compare to Other Indian Fentanyl Exporters?

What Fentanyl Formulations Does Venor Pharma Limited Export?

How Does Venor Pharma Limited Compare to Nearest Fentanyl Exporters?

Which Indian Ports Ship Fentanyl Exports?

What Other Analgesics & Antipyretics Products Does Venor Pharma Limited Export?

Fentanyl — Export Intelligence Video

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Fentanyl Exports

Venor Pharma Limited — Regulatory Compliance & Quality Standards

About Venor Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fentanyl Export Data from Venor Pharma Limited

Fentanyl Stats

Company Overview

Top Products by Venor Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source